These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 8255364

  • 1. Effects of CGP 28014 on the in vivo release and metabolism of dopamine in the rat striatum assessed by brain microdialysis.
    Steulet AF, Stöcklin K, Wicki P, Waldmeier P.
    Neurochem Res; 1993 Nov; 18(11):1131-6. PubMed ID: 8255364
    [Abstract] [Full Text] [Related]

  • 2. Modulation of rat brain endogenous dopamine metabolism by new inhibitors of catechol O-methyltransferase.
    Törnwall M, Tuomainen P, Männistö PT.
    Eur J Pharmacol; 1993 Aug 03; 239(1-3):39-45. PubMed ID: 8223912
    [Abstract] [Full Text] [Related]

  • 3. [Microdialysis study of tolcapone effect during blockage of neuronal dopamine reuptake caused by GBR-12909].
    Budygin EA, Gaĭnetdinov RR, Raevskiĭ KS, Li IH, Mannisto PT.
    Eksp Klin Farmakol; 1997 Aug 03; 60(5):8-10. PubMed ID: 9483396
    [Abstract] [Full Text] [Related]

  • 4. Different in vivo properties of three new inhibitors of catechol O-methyltransferase in the rat.
    Männistö PT, Tuomainen P, Tuominen RK.
    Br J Pharmacol; 1992 Mar 03; 105(3):569-74. PubMed ID: 1628144
    [Abstract] [Full Text] [Related]

  • 5. Comparison of two new inhibitors of catechol O-methylation on striatal dopamine metabolism: a microdialysis study in rats.
    Törnwall M, Kaakkola S, Tuomainen P, Kask A, Männistö PT.
    Br J Pharmacol; 1994 May 03; 112(1):13-8. PubMed ID: 7518301
    [Abstract] [Full Text] [Related]

  • 6. Effect of intracerebral 6-nitronoradrenaline, an endogenous catechol-O-methyltransferase (COMT) inhibitor, on striatal dopamine metabolism in anaesthetised rats.
    Huotari M, Passlin M, Nordberg HL, Forsberg M, Kotisaari S, Tuomisto L, Shintani F, Tanaka KF, Reenilä I, Laitinen K, Männistö PT.
    J Neurosci Methods; 2001 Aug 15; 109(1):47-52. PubMed ID: 11489299
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CGP 28014, a new inhibitor of cerebral catechol-O-methylation with a non-catechol structure.
    Waldmeier PC, Baumann PA, Feldtrauer JJ, Hauser K, Bittiger H, Bischoff S, von Sprecher G.
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Sep 15; 342(3):305-11. PubMed ID: 1980718
    [Abstract] [Full Text] [Related]

  • 11. Effects of peripheral and central catechol-O-methyltransferase inhibition on striatal extracellular levels of dopamine: a microdialysis study in freely moving rats.
    Napolitano A, Bellini G, Borroni E, Zürcher G, Bonuccelli U.
    Parkinsonism Relat Disord; 2003 Jan 15; 9(3):145-50. PubMed ID: 12573869
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of catechol-O-methyltransferase inhibitors and L-3,4-dihydroxyphenylalanine with or without carbidopa on extracellular dopamine in rat striatum.
    Kaakkola S, Wurtman RJ.
    J Neurochem; 1993 Jan 15; 60(1):137-44. PubMed ID: 8417137
    [Abstract] [Full Text] [Related]

  • 18. Modulation of hippocampal dopamine metabolism and hippocampal-dependent cognitive function by catechol-O-methyltransferase inhibition.
    Laatikainen LM, Sharp T, Bannerman DM, Harrison PJ, Tunbridge EM.
    J Psychopharmacol; 2012 Dec 15; 26(12):1561-8. PubMed ID: 22815336
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of the new selective COMT inhibitor CGP 28014 A on the formation of 3-O-methyldopa (3OMD) in plasma of healthy subjects.
    Bieck PR, Nilsson E, Antonin KH.
    J Neural Transm Suppl; 1990 Dec 15; 32():387-91. PubMed ID: 2128511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.